首页> 中文期刊> 《分子细胞生物学报:英文版》 >Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19

Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19

         

摘要

Although millions of patients have clinically recovered from COVID-19,little is known about the immune status of lymphocytes in these individuals.In this study,the peripheral blood mononuclear cells of a clinically recovered(CR)cohort were comparatively analyzed with those of an age-and sex-matched healthy donor cohort.We found that CD8^(+)T cells in the CR cohort had higher numbers of effector T cells and effector memory T cells but lower Tc1(IFN-γ^(+)),Tc2(IL-4^(+)),and Tc17(IL-17A^(+))cell frequencies.The CD4^(+)T cells of the CR cohort were decreased in frequency,especially the central memory T cell subset.Moreover,CD4^(+)T cells in the CR cohort showed lower programmed cell death protein 1(PD-1)expression and had lower frequencies of Th1(IFN-γ^(+)),Th2(IL-4^(+)),Th17(IL-17A^(+)),and circulating follicular helper T(CXCR5^(+)PD-1^(+))cells.Accordingly,the proportion of isotype-switched memory B cells(IgM−CD20^(hi))among B cells in the CR cohort showed a significantly lower proportion,although the level of the activation marker CD71 was elevated.For CD3−HLA-DR−lymphocytes in the CR cohort,in addition to lower levels of IFN-γ,granzyme B and T-bet,the correlation between T-bet and IFN-γ was not observed.Additionally,by taking into account the number of days after discharge,all the phenotypes associated with reduced function did not show a tendency toward recovery within 4-11 weeks.The remarkable phenotypic alterations in lymphocytes in the CR cohort suggest that severe acute respiratory syndrome coronavirus 2 infection profoundly affects lymphocytes and potentially results in dysfunction even after clinical recovery.

著录项

  • 来源
    《分子细胞生物学报:英文版》 |2021年第3期|197-209|共13页
  • 作者单位

    Shanghai Public Health Clinical Center;

    Fudan University;

    Shanghai 201508;

    China;

    Institute of Infection;

    Immunology and Tumor Microenvironment;

    Hubei Province Key Laboratory of Occupational Hazard Identification and Control;

    Medical College;

    Wuhan University of Science and Technology;

    Wuhan 430065;

    China;

    Joint Laboratory of Infectious Diseases and Health;

    Wuhan Institute of Virology&Wuhan Jinyintan Hospital;

    Wuhan Institute of Virology;

    Center for Biosafety Mega-Science;

    Chinese Academy of Sciences;

    Wuhan 430023;

    China;

    State Key Laboratory of Virology;

    Wuhan Institute of Virology;

    Center for Biosafety Mega-Science;

    Chinese Academy of Sciences;

    Wuhan 430071;

    China;

    Center for Translational Medicine;

    Jinyintan Hospital;

    Wuhan 430023;

    China;

    Joint Laboratory of Infectious Diseases and Health;

    Wuhan Institute of Virology&Wuhan Jinyintan Hospital;

    Wuhan Jinyintan Hospital;

    Wuhan 430023;

    China;

    Department of Laboratory Medicine;

    Maternal and Child Health Hospital of Hubei Province;

    Tongji Medical College;

    Huazhong University of Science and Technology;

    Wuhan 430070;

    China;

    School of Public Health(Shenzhen);

    Sun Yat-sen University;

    Shenzhen 518107;

    China;

    Institute of Medical Biology;

    Chinese Academy of Medical Sciences&Peking Union Medical College;

    Kunming 650018;

    China;

    University of Chinese Academy of Sciences;

    Beijing 100049;

    China;

    The Office of Drug Clinical Trial Institution;

    Jinyintan Hospital;

    Wuhan 430023;

    China;

    Department of Critical Care Medicine;

    Union Hospital;

    Tongji Medical College;

    Huazhong University of Science and Technology;

    Wuhan 430030;

    China;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 肿瘤学;
  • 关键词

    COVID-19; recovered individuals; lymphocyte subsets; phenotypic alteration; potential dysfunction;

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号